Best treatments for hypertrophic cardiomyopathy
2 products may treat hypertrophic cardiomyopathy, spanning FDA drug classes such as cardiac myosin inhibitor. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 2 drugs we list for hypertrophic cardiomyopathy, none are yet flagged as generics in our price data, spanning classes such as cardiac myosin inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for hypertrophic cardiomyopathy — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Capsule | Cardiac Myosin Inhibitor | No data | — | View → | |
| 2 | Not yet rated | Prescription | Tablet | — | No data | — | View → |
Full ranking · 2 treatments
camzyos
Boxed warningPrescriptionFDA-sourced
Camzyos (Mavacamten) is a cardiac myosin inhibitor used to treat Hypertrophic Cardiomyopathy.
Price varies
myqorzo
Boxed warningPrescriptionFDA-sourced
Myqorzo (Aficamten) is a medication used to treat Hypertrophic Cardiomyopathy.
Price varies
Frequently asked
- What treats hypertrophic cardiomyopathy?
- Our catalog lists 2 products that may treat hypertrophic cardiomyopathy, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.
- What is the best-rated treatment for hypertrophic cardiomyopathy?
- Ratings appear as FDA recall-safety data accumulates for the products that may treat hypertrophic cardiomyopathy.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat hypertrophic cardiomyopathy?
- Treatments for hypertrophic cardiomyopathy span FDA drug classes including cardiac myosin inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.